We are assessing whether JJP-1212 is safe and can effectively stimulate an immune response in humans. This study aims to understand its tolerability and potential benefits.
Health conditions and diseases that the clinical trial is designed to study and treat.
Linear IgA Bullous Dermatosis (LAD) is a rare autoimmune skin disorder that causes blistering and lesions on the skin, often accompanied by itching. It is characterized by the presence of linear IgA antibodies in the skin.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.